294 related articles for article (PubMed ID: 17920041)
21. Lovastatin suppresses invasiveness of anaplastic thyroid cancer cells by inhibiting Rho geranylgeranylation and RhoA/ROCK signaling.
Zhong WB; Liang YC; Wang CY; Chang TC; Lee WS
Endocr Relat Cancer; 2005 Sep; 12(3):615-29. PubMed ID: 16172195
[TBL] [Abstract][Full Text] [Related]
22. A novel role for RhoGDI as an inhibitor of GAP proteins.
Hancock JF; Hall A
EMBO J; 1993 May; 12(5):1915-21. PubMed ID: 8491184
[TBL] [Abstract][Full Text] [Related]
23. Modulation of COX-2 expression by statins in human aortic smooth muscle cells. Involvement of geranylgeranylated proteins.
Degraeve F; Bolla M; Blaie S; Créminon C; Quéré I; Boquet P; Lévy-Toledano S; Bertoglio J; Habib A
J Biol Chem; 2001 Dec; 276(50):46849-55. PubMed ID: 11591701
[TBL] [Abstract][Full Text] [Related]
24. cAMP-induced AQP2 translocation is associated with RhoA inhibition through RhoA phosphorylation and interaction with RhoGDI.
Tamma G; Klussmann E; Procino G; Svelto M; Rosenthal W; Valenti G
J Cell Sci; 2003 Apr; 116(Pt 8):1519-25. PubMed ID: 12640036
[TBL] [Abstract][Full Text] [Related]
25. Serine 34 phosphorylation of rho guanine dissociation inhibitor (RhoGDIalpha) links signaling from conventional protein kinase C to RhoGTPase in cell adhesion.
Dovas A; Choi Y; Yoneda A; Multhaupt HA; Kwon SH; Kang D; Oh ES; Couchman JR
J Biol Chem; 2010 Jul; 285(30):23296-308. PubMed ID: 20472934
[TBL] [Abstract][Full Text] [Related]
26. Activity of the Bcr GTPase-activating domain is regulated through direct protein/protein interaction with the Rho guanine nucleotide dissociation inhibitor.
Kweon SM; Cho YJ; Minoo P; Groffen J; Heisterkamp N
J Biol Chem; 2008 Feb; 283(6):3023-3030. PubMed ID: 18070886
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of protein geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis in human endothelial cells.
Li X; Liu L; Tupper JC; Bannerman DD; Winn RK; Sebti SM; Hamilton AD; Harlan JM
J Biol Chem; 2002 May; 277(18):15309-16. PubMed ID: 11839765
[TBL] [Abstract][Full Text] [Related]
28. Lovastatin enhances clearance of apoptotic cells (efferocytosis) with implications for chronic obstructive pulmonary disease.
Morimoto K; Janssen WJ; Fessler MB; McPhillips KA; Borges VM; Bowler RP; Xiao YQ; Kench JA; Henson PM; Vandivier RW
J Immunol; 2006 Jun; 176(12):7657-65. PubMed ID: 16751413
[TBL] [Abstract][Full Text] [Related]
29. Divergence of Rho residue 43 impacts GEF activity.
Sloan CM; Quinn CV; Peters JP; Farley J; Goetzinger C; Wernli M; DeMali KA; Ellerbroek SM
Small GTPases; 2012; 3(1):15-22. PubMed ID: 22673745
[TBL] [Abstract][Full Text] [Related]
30. The role of geranylgeranylated proteins in human mesangial cell proliferation.
Khwaja A; Sharpe CC; Noor M; Hendry BM
Kidney Int; 2006 Oct; 70(7):1296-304. PubMed ID: 16929252
[TBL] [Abstract][Full Text] [Related]
31. Differential localization of Rho GTPases in live cells: regulation by hypervariable regions and RhoGDI binding.
Michaelson D; Silletti J; Murphy G; D'Eustachio P; Rush M; Philips MR
J Cell Biol; 2001 Jan; 152(1):111-26. PubMed ID: 11149925
[TBL] [Abstract][Full Text] [Related]
32. Disruption of RhoGDI and RhoA regulation by a Rac1 specificity switch mutant.
Wong KW; Mohammadi S; Isberg RR
J Biol Chem; 2006 Dec; 281(52):40379-88. PubMed ID: 17074770
[TBL] [Abstract][Full Text] [Related]
33. Role of isoprenylcysteine carboxylmethyltransferase-catalyzed methylation in Rho function and migration.
Cushman I; Casey PJ
J Biol Chem; 2009 Oct; 284(41):27964-27973. PubMed ID: 19651782
[TBL] [Abstract][Full Text] [Related]
34. Phosphorylation states of Cdc42 and RhoA regulate their interactions with Rho GDP dissociation inhibitor and their extraction from biological membranes.
Forget MA; Desrosiers RR; Gingras D; Béliveau R
Biochem J; 2002 Jan; 361(Pt 2):243-54. PubMed ID: 11772396
[TBL] [Abstract][Full Text] [Related]
35. Rabbit intestine contains a protein that inhibits the dissociation of GDP from and the subsequent binding of GTP to rhoB p20, a ras p21-like GTP-binding protein.
Ohga N; Kikuchi A; Ueda T; Yamamoto J; Takai Y
Biochem Biophys Res Commun; 1989 Sep; 163(3):1523-33. PubMed ID: 2506864
[TBL] [Abstract][Full Text] [Related]
36. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase.
Laufs U; Liao JK
J Biol Chem; 1998 Sep; 273(37):24266-71. PubMed ID: 9727051
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of lysophosphatidic acid-induced RhoA activation and tumor cell invasion by 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors.
Kusama T; Mukai M; Ayaki M; Imamura F; Tatsuta M; Matsumoto Y; Nakamura H; Inoue M
Int J Oncol; 2003 Oct; 23(4):1173-8. PubMed ID: 12964001
[TBL] [Abstract][Full Text] [Related]
38. A Complete Survey of RhoGDI Targets Reveals Novel Interactions with Atypical Small GTPases.
Ahmad Mokhtar AMB; Ahmed SBM; Darling NJ; Harris M; Mott HR; Owen D
Biochemistry; 2021 May; 60(19):1533-1551. PubMed ID: 33913706
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of statin-mediated inhibition of small G-protein function.
Cordle A; Koenigsknecht-Talboo J; Wilkinson B; Limpert A; Landreth G
J Biol Chem; 2005 Oct; 280(40):34202-9. PubMed ID: 16085653
[TBL] [Abstract][Full Text] [Related]
40. Regulation of Leukaemia Associated Rho GEF (LARG/ARHGEF12).
Ghanem NZ; Matter ML; Ramos JW
Small GTPases; 2022 Jan; 13(1):196-204. PubMed ID: 34304710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
